News
ESAIY
6.10
+3.39%
0.20
Weekly Report: what happened at ESAIY last week (0608-0612)?
Weekly Report · 3d ago
Weekly Report: what happened at ESAIY last week (0601-0605)?
Weekly Report · 06/08 09:36
Weekly Report: what happened at ESAIY last week (0525-0529)?
Weekly Report · 06/01 09:38
Leqembi Isn't Enough To Save Biogen Momentum (Rating Downgrade)
Seeking Alpha · 05/26 12:11
Weekly Report: what happened at ESAIY last week (0518-0522)?
Weekly Report · 05/25 09:40
Weekly Report: what happened at ESAIY last week (0511-0515)?
Weekly Report · 05/18 09:40
Weekly Report: what happened at ESAIY last week (0504-0508)?
Weekly Report · 05/11 09:38
Biogen says FDA extends review of Leqembi alzheimer’s injection
Seeking Alpha · 05/08 06:52
Weekly Report: what happened at ESAIY last week (0427-0501)?
Weekly Report · 05/04 09:38
Biogen trims full-year earnings outlook on BD impact
Seeking Alpha · 04/29 10:34
Weekly Report: what happened at ESAIY last week (0420-0424)?
Weekly Report · 04/27 09:38
Merck, Eisai face setback in late-stage trial for Keytruda regimen in kidney cancer
Seeking Alpha · 04/21 11:36
Weekly Report: what happened at ESAIY last week (0413-0417)?
Weekly Report · 04/20 09:37
These Alzheimer’s drugs were supposed to revolutionize the way we fight the disease. The reality is more complicated.
MarketWatch · 04/18 13:00
Weekly Report: what happened at ESAIY last week (0406-0410)?
Weekly Report · 04/13 09:38
Zai Lab: Xacduro And ZL-1310 Drive Growth Narrative
Seeking Alpha · 04/06 13:02
Weekly Report: what happened at ESAIY last week (0330-0403)?
Weekly Report · 04/06 09:39
Weekly Report: what happened at ESAIY last week (0323-0327)?
Weekly Report · 03/30 09:38
Nuvation Bio, Eisai application for taletrectinib for NSCLC accepted by EMA
Seeking Alpha · 03/26 21:26
Weekly Report: what happened at ESAIY last week (0316-0320)?
Weekly Report · 03/23 09:37
More
Webull provides a variety of real-time ESAIY stock news. You can receive the latest news about Eisai Co Ltd through multiple platforms. This information may help you make smarter investment decisions.
About ESAIY
Eisai Co Ltd is a Japan-based pharmaceutical company mainly engaged in the research and development, manufacture, sale, import and export of pharmaceuticals. The Company operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The segment operates in five regions including Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Russia, Oceania), Asia and Latin America (Korea, Taiwan, India, ASEAN, Latin America). The Others segment is involved in license revenues and pharmaceutical raw materials business. The Company is also engaged in the provision of brands such as the anticancer drugs Lembima and Halaven on the nerve and oncology areas.